A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection-Reference-Cited by-同舟云学术

A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection

Published:2023-01 Issue:1 Volume:163 Page:64-76
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Guan Wei-jie,Xu Jin-fu,Luo Hong,Xu Xing-xiang,Song Yuan-lin,Ma Wan-li,Liang Zong-an,Liu Xue-dong,Zhang Guo-jun,Zhang Xiao-ju,Li Rong-kai,Zhu Shu-yang,Zhang Yi-jie,Cai Xing-jun,Wei Li-ping,Tian Dong-bo,Zhao Hui,Chen Ping-yan,Qu Jie-ming,Zhong Nan-shan

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference29 articles.

1. British Thoracic Society guideline for non-CF bronchiectasis;Pasteur;Thorax,2010

2. Increased intracellular Cl– concentration promotes ongoing inflammation in airway epithelium;Zhang;Mucosal Immunol,2018

3. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis;Chalmers;Am J Respir Crit Care Med,2012

4. Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis;Martinez-García;Clin Microbiol Infect,2021

5. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival;Loebinger;Eur Respir J,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficacy and Safety of Inhaled Antibiotics for the Treatment of Bronchiectasis in Adults;CHEST;2024-07

2. Intravenous Tobramycin Inhalation for Patients With Advanced Bronchiectasis With Pseudomonas aeruginosa Infection in Home Medical Care: A Report of Two Cases;Cureus;2024-06-19

3. Bronchiectasis management in adults: state of the art and future directions;European Respiratory Journal;2024-05-23

4. Inhaled dry powder liposomal azithromycin for treatment of chronic lower respiratory tract infection;International Journal of Pharmaceutics;2024-03

5. A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution forPseudomonas aeruginosaeradication in bronchiectasis: ERASE;ERJ Open Research;2024-01